Studies have shown in humans and other species that the major histocompatibility complex class I (MHC-I) region is involved at a number of levels in the establishment and maintenance of pregnancy. The aim of this study was to characterize how a bovine nonclassical MHC-I gene (NC1) is regulated. Initial serial deletion experiments of a 2-kb fragment of the NC1 promoter identified regions with positive regulatory elements in the proximal promoter and evidence for a silencer module(s) further upstream that cooperatively contributed to constitutive NC1 expression. The cytokines interferon tau (IFNT), interferon gamma (IFNG), and interleukin 4 (IL4) significantly increased luciferase expression in NC1 promoter reporter constructs and endogenous NC1 mRNA levels in a bovine endometrial cell line. In addition, IFNG, IL3, IL4, and progesterone significantly increased Day 7 bovine blastocyst NC1 mRNA expression when supplemented during in vitro embryo culture. Site-directed mutagenesis analysis identified a STAT6 binding site that conferred IL4 responsiveness in the NC1 proximal promoter. Furthermore, methylation treatment of the proximal promoter, which contains a CpG island, completely abrogated constitutive NC1 expression. Overall, the findings presented here suggest that constitutive NC1 expression is regulated positively by elements in the proximal promoter, which are further controlled by upstream silencer modules. The promoter is responsive to IFNT, IFNG, and IL4, suggesting possible roles for these cytokines in bovine preimplantation embryo survival and/or maternal-fetal tolerance. Our studies also suggest that methylation of the proximal promoter, in particular, could play a significant role in regulating NC1 expression.
INTRODUCTION
Commercial dairy cattle experience relatively high rates (;40%) of embryonic and fetal mortality despite fertilization rates of 90%, with the majority (70%-80%) of losses occurring between Days 8 and 16 postinsemination (recently reviewed by [1] ). There are many reasons relating to both the dam and embryo why implantation fails. However, it is known that the major histocompatibility complex (MHC) is involved in preimplantation embryo development and fetal-maternal interactions, where the maternal immune system must tolerate a semiallograft [2] . The MHC region contains class I and II genes [3, 4] . Class II molecules function to present pathogen-derived peptides to T-helper cells, thus alerting the immune system to infection. The class I region of the MHC includes both the polymorphic classical (class Ia) and nonclassical (class Ib) genes. Class Ib genes have limited polymorphism and often display tissue-specific or restricted expression patterns [5] . MHC class Ia cell surface-expressed glycoproteins present antigens to cytotoxic T cells, and both Ia and Ib molecules are involved in the activation or inhibition of natural killer (NK) cell responses [6, 7] . Nonclassical class I molecules in particular have been associated with successful reproduction in humans and mice [2] .
In humans, much research has focused on the role of the nonclassical MHC-I molecule HLA-G both as a marker for efficient embryo implantation after in vitro fertilization (IVF) and as a tolerogenic mediator at the maternal-fetal interface [8] [9] [10] . HLA-G is expressed on extravillous human fetal trophoblast cells and may also potentiate maternal immunotolerance through modulation of CD4 þ T, CD8 þ T, and NK cell activity [11] [12] [13] . A recent literature survey on the role of soluble HLA-G (sHLA-G) reported that sHLA-G secreted by early embryos may be necessary for implantation and could represent a good noninvasive marker for pregnancy rate following IVF [14, 15] . However, the association between sHLA-G and implantation success is not robust, and studies are ongoing to establish the significance of the relationship [16] . The other human nonclassical MHC-I molecules HLA-C and HLA-E are also expressed on extravillous human fetal trophoblast cells [17] . HLA-E is ubiquitously expressed in body tissues and is known to inhibit NK cell activity; however, the cellular expression of HLA-E is dependent on the concurrent expression of either HLA-G or HLA-C. Thus, the modulatory effect of HLA-G on maternal immune-tolerance may be mediated through HLA-E [18] . In mice, the nonclassical Mhc-I preimplantation embryo development (Ped) gene, whose protein product was found to be the Qa2 antigen [19] , controls the cleavage rate and subsequent survival of preimplantation embryos [20, 21] . Two functional alleles of the Ped gene, termed Ped fast and Ped slow, determine the rate of embryo cleavage, a variable highly correlated with the ability of the embryo to reach the blastocyst stage [20] . Evidence suggests that HLA-G is a potential candidate for the functional human homolog of the mouse Ped gene, indicating the closely associated roles that these two nonclassical molecules share in early embryo development, survival, and reproductive success [22] .
The MHC is known as the bovine leukocyte antigen (BoLA) in cattle. The existence and genomic location on chromosome 23 of four bovine MHC class Ib genes (named NC1-NC4) was recently demonstrated [23, 24] . The NC1 gene was found to be located close to the classical MHC class Ia genes, while NC2-NC4 were located some 500 kb centromeric to the classical cluster [23] . This study also determined the nonclassical gene content between haplotypes using cattle typed as MHC-1 homozygous, with distinct classical class I gene arrangements. Interestingly, NC1 was found on all haplotypes examined, potentially suggesting an important or conserved function in cattle. In common with HLA-G, NC1 exhibits very limited polymorphism and has an early termination codon leading to a molecule with a truncated cytoplasmic domain. Some alleles have a termination codon at the end of the transmembrane domain, and a number of isoforms have been described, one of which has no transmembrane domain, potentially generating soluble NC1 molecules. Unlike HLA-G, but in common with HLA-E, NC1 is transcribed in many cell types, although protein expression cannot be demonstrated at present because of a lack of a specific monoclonal antibody [23, 24] . A study involving bovine papilloma virus-4 (BPV-4) demonstrated that while bovine classical MHC-I is effectively downregulated by the virus, it has no effect on NC1 [25] . Human papilloma virus, in common with many other viruses, is known to only downregulate expression of classical MHC-I as a means to evade the innate immune system because nonclassical MHC-I left at the cell surface can send a protective (inhibitory) signal via interaction with NK receptors [26] . NC1 may be implicated in similar interactions with NK cells [25] .
Studies examining the expression of the NC1 gene in embryos and reproductive tissues of cattle are limited. We have recently described the mRNA expression pattern of NC1 during preimplantation embryo development in cattle and found the highest levels of expression in metaphase II stage oocytes and presumptive zygotes [27] . Additionally, generic primers, which were compatible with classical MHC-I and NC1 alleles, detected 10% of blastocyst cDNA sequences as NC1 [27] . Expression of NC1 was also detected in bovine trophoblast cells and at higher levels than in peripheral blood mononuclear cells [24] . To date, the function of bovine nonclassical class I genes remains unknown. However, it has been suggested that the NC1 gene, which has a number of splice variants [23] , could encode both membrane-bound and soluble forms of the protein and thus influence immunotolerance in cattle [24] .
Nonclassical MHC-I molecules have been shown to play important roles in successful human and mouse reproduction. The recently identified and mapped bovine NC1 gene represents a promising candidate for further study. NC1 is present on all MHC haplotypes studied and is transcribed both in early bovine embryos and trophoblast cells. MHC-I expression is regulated during embryo development [28] . Transcriptional regulation of MHC-I is controlled through transcription factor binding sites in the promoter regions of the MHC-I genes that can be regulated either directly or indirectly by various cytokines [29] [30] [31] . The aim of this study is to establish how the NC1 gene is regulated constitutively and furthermore to identify modulators of NC1 expression. A panel of embryo-and/or endometrial-secreted cytokines and the pregnancy-associated hormone progesterone (P4) were chosen because of their previously reported roles in regulating MHC-I expression in JEG3 choriocarcinoma cells (leukemia inhibitory factor (LIF) [32, 33] ; P4 [34] ), preimplantation mouse embryos (interferon gamma (IFNG) [35] ), human decidual stroma cells (interleukin (IL) 10 [36, 37] ), ovine endometrial stroma and glandular epithelium (interferon tau (IFNT) [38] ), and/or the establishment and maintenance of pregnancy (LIF [39] [40] [41] [42] ; IL4 [43, 44] ; IL3 [45] ; IL10 [37, 46] ; IFNT [38, 47] , granulocytecolony stimulating factor (G-CSF, official symbol CSF3) [48, 49] ; P4 [50] ) or enhanced embryo development when added to vitro embryo culture conditions (IL1B [51, 52] ; granulocytemacrophage colony-stimulating factor (GM-CSF, official symbol CSF2) [48, 53] ; G-CSF (CSF3) [49] ; IFNG [35] ).
MATERIALS AND METHODS

Construction of NC1 Promoter Reporter Vectors
The genomic region of NC1 spanning 2 kb upstream and 100 bp downstream of the transcriptional start site (TSS) was extracted from the NCBI GenBank and Ensembl Cow genome databases [54, 55] . Bioinformatic analysis was performed using software tools within the GenomatixSuite, including Gene2Promoter to retrieve and analyze the NC1 promoter and MatInspector to identify transcription factor binding sites (Genomatix Software, GmbH, Munich, Germany). The promoter sequence was screened for interspersed repeats prior to primer design using the RepeatMasker program [56] . Primers were designed to target nonrepetitive sequences and modified to contain XhoI and HindIII restriction sites for directional cloning. The largest promoter fragment (À1829/þ74) was amplified using 1 international unit (IU) of Phusion High-Fidelity DNA polymerase (Finnzymes Oy, Espoo, Finland) and a final concentration of 200 lM of each deoxynucleotide triphosphate (Promega, Madison, WI), 200 nM of each primer (NC1-F.1 and NC1-R.1) (Eurofins MWG Operon, Ebersberg, Germany), and 100 ng of Holstein Friesian genomic DNA as template in a 50-ll PCR reaction. The cycling protocol was initial denaturation at 988C for 30 sec, followed by 30 cycles of 988C for 10 sec, 748C-788C for 15-30 sec, and 728C for 45 sec, with a final extension at 728C for 10 min (see Table 1 for primer sequences and specific conditions cycling conditions). The PCR products and the pGL4.17 luciferase vector (Promega) were digested with XhoI and HindIII (New England Biolabs, Ipswich, MA) at 378C for 2 h and purified with either a PCR cleanup kit or Gel Extraction kit (Qiagen, West Sussex, UK). Purified PCR product was ligated into digested pGL4.17 vector using 1 U of T4 DNA ligase (Roche Diagnostics GmbH, Mannheim, Germany) in a 10 ll reaction at 188C overnight. The ligated product was transformed into One Shot OmniMAX chemically competent Escherichia coli cells (Invitrogen, Carlsbad, CA) following the manufacturer's instructions. Plasmids were initially purified from overnight cultures using a Plasmid Mini Kit (Qiagen) and sequenced for verification of the correct insert (MWG Biotech AG; Eurofins MWG Operon, Ebersberg, Germany). Constructs with correct inserts were then purified with a High Speed Plasmid Maxi Kit (Qiagen) and eluted in endotoxin-free 10 mM Tris, 1 mM ethylenediaminetetraacetic acid, pH 8.0. The DNA concentrations were determined by spectrophotometry (Nanodrop Technologies, Inc., Wilmington, DE). The 1904 bp NC1 construct (100 ng) was used as the template for all subsequent PCRs to generate the NC1 serial deletion constructs using the primers and cycling conditions detailed in Table 1 .
Site-Directed Mutagenesis
Site-directed mutagenesis was performed on a STAT6 transcription factor binding site within the p-265/þ74 NC1 proximal promoter construct (located 51 bp upstream of TSS) to determine if it contributed to IL4 responsiveness. STAT6 binds to the highly conserved palandromic sequence motif TTC (N) [2] [3] [4] GAA [57] . The 340 bp sequence was initially analyzed using the SequenceShaper software tool with the GenomatixSuite (Genomatix Software, GmbH). Three base pairs within the STAT6 binding site were predicted to disrupt STAT6 binding, when mutated, without introducing or removing other binding sites. These changes were as follows: (A/G) (A/G) (A/C) where TTCTAGAGAA represents normal STAT6 and TTCTAGGGGC represents mutated STAT6. Four primers were designed to generate a mutated STAT6 NC1 proximal promoter. Two primers (previously used for cloning: NC1-F.6 and NC1-R) were designed toward the 5 0 and 3 0 ends to amplify the entire 340 bp region and contained XhoI and HindIII restriction sites for cloning. Two additional complementary primers (STAT6-F and STAT6-R) were designed to overlap the mutagenesis site and introduce the mutated STAT6 site. Two PCR reactions were set up with 200 nM of each primer (NC1-F.6, STAT6-R and NC1-R, STAT6-F) (see Table 2 ) in a 50 ll PCR reaction with Phusion HighFidelity DNA polymerase (Finnzymes Oy) and 10 ng of p-265/þ74 NC1 plasmid preparation as described above. The cycling protocol was initial denaturation at 988C for 30 sec, followed by 30 cycles of 988C for 10 sec, 758C
CHARACTERIZATION OF THE BOLA-NC1 PROMOTER 297 for 30 sec, and 728C for 15 sec, with a final extension at 728C for 10 min. Both PCR products were purified using a Gel Extraction kit (Qiagen). A subsequent PCR reaction was set up as described above with 10 ng of both purified PCR products as template and 200 nM of each primer (NC1-F.6 and NC1-R) with the following cycling protocol: denaturation at 988C for 30 sec, followed by 30 cycles of 988C for 10 sec, 748C for 30 sec, and 728C for 15 sec, with a final extension at 728C for 10 min. The product was confirmed as a single band of correct size on 1% ethidium bromide agarose gel and subsequently cloned into the pGL4.17 luciferase vector (Promega) as described above.
Cell Culture
The bovine endometrial (BEND) cell line (CRL-2398) was purchased from ATCC (LGC Standards, U.K.) and cultured in 75 cm 2 flasks (CELLSTAR, Cruinn Diagnostics Ltd., Dublin, Ireland) in 5% CO 2 in air in a 378C incubator. This cell line has been previously well characterized [58] and has been previously used in gene promoter characterization studies (e.g., [59] ). Complete growth medium consisted of a 1:1 mixture of Hams F12 medium and Eagle minimal essential medium with Earle BSS (D-valine modification) and 1.5 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate supplemented with 34 mg/L D-valine (Sigma-Aldrich Ireland Ltd., Dublin, Ireland), 10% heatinactivated fetal bovine serum, 10% heat-inactivated horse serum (Gibco Invitrogen), and a final concentration of 50 U penicillin and 50 lg of streptomycin (Gibco Invitrogen). Complete medium was replaced every 2-3 days, and cells were passaged either once a week or at ;80% confluency with a 1:4 subcultivation ratio.
Transient Transfections, Treatments, and Luciferase Reporter Assays BEND cell cultures were subcultivated 2-3 days before seeding. Cells were seeded in 12-well plates (CELLSTAR) at a density of 5 3 10 4 cells per well in 1 ml of media and allowed to adhere for 24-48 h. All transient cotransfection experiments for luciferase reporter assays were carried out in triplicate using 100 ng of each of the NC1-pGL4.17 maxipreparations together with 10 ng of a renilla control vector (pGL4.74) using 1.5 ll of GeneJuice transfection reagent (Novagen, Merck Biosciences Ltd., Nottingham, UK) per well according to the manufacturer's instructions. The transfection mixture was removed after 16 h and replaced with either complete growth media or media supplemented with serial dilutions (1, 10, or 100 ng/ml, unless otherwise stated) of IL1B, IL3, IL4, IL10, GM-CSF (CSF2), LIF (AbD Serotec, Kidlington, UK), P4 (3.14, 31.4, or 314 ng/ml) (Sigma-Aldrich Ireland Ltd.), IFNG (Thermo Fisher Scientific, Rockford, IL), recombinant IFNT (a gift from Dr. Gilles Charpigny, INRA, France), or G-CSF (a gift from Dr. Francis Frankenne, University of Liege, Belgium) for 24 h. Medium was removed and cells were washed with PBS, lysed with 250 ll of freshly prepared 1X passive lysis buffer solution (Promega), and placed on a horizontal shaker for 20 min at 900 rpm. Lysates were analyzed for luciferase and renilla levels using the Dual Luciferase Reporter assay system on a GloMax 20/20 luminometer (Promega) with automatic injectors using 20 ll of lysate and programmed to inject 100 ll of freshly prepared luciferase assay and Stop and Glo reagent. Expression of luciferase in relative light units (RLU) was normalized to the renilla control and expressed as a ratio.
qRT-PCR Gene Expression Analysis
BEND cells for qRT-PCR analysis were seeded into 12-well plates and allowed to adhere as described above. Cells were treated with media supplemented with 10 ng/ml of IFNG, IFNT, or IL4 for 24 h. RNA was isolated and purified using an RNeasy Plus Mini Kit with a gDNA (genomic DNA) eliminator column (Qiagen) according to the manufacturer's instructions. The integrity and quantity of the RNA was determined by examining the RNA integrity number and the 18S/28S ratio using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA). A High Capacity cDNA Reverse Transcription kit (Applied Biosystems, Inc., Foster City, CA) was used to convert 250 ng of each RNA sample to cDNA using random primers in a 20 ll reaction. Quantitative RT-PCR reactions were performed on an Mx3000P instrument (Stratagene, Agilent Technologies Inc., Santa Clara, CA) using Brilliant II SYBR Green QPCR Master Mix (Stratagene) with the following cycling parameters: 958C for 10 min (hot start), 40-45 cycles of 958C for 15 sec and annealing at 608C for 1 min, followed by dissociation curve analysis (958C for 1 min, 558C for 30 sec, increasing 0.58C/cycle for 81 cycles). Each reaction was carried out in a total volume of 25 ll, with 5 ll of a 1:10 dilution of cDNA, 12.5 ll of master mix, 6 ll H 2 O, and 1.5 ll of primer mix. Optimal primer concentrations were determined by examining the dissociation curve from qRT-PCR reactions with 100, 300, and 900 nM final concentration of primer (see Table 3 ). Serial dilutions of a reference cDNA sample were prepared for standard curve analysis to determine the primer efficiency and for relative quantification of gene expression 
In Silico CpG Island and In Vitro Methylation Analysis
The proximal promoter region (À577/þ74) of the NC1 gene was analyzed for the presence of clusters of CpG dinucleotides, or CpG islands, using the online software tool CpG Island Searcher (www.cpgislands.com) [61] . The lower limits were set at %GC ¼ 55, ObsCpG/ExpCpG ¼ 0.65, length ¼ 300 bp, and distance ¼ 100. In vitro methylation of the NC1 proximal promoter reporter constructs (À577/þ74) and the pGL4.17 empty vector was performed using the CpG methyltransferase enzyme (M.SssI; New England Biolabs), which methylates all cytosine residues (C 5 ) within the double-stranded dinucleotide recognition sequence 5 0 ...CG...3 0 , according to the manufacturer's instructions. Briefly, 2 lg of each construct were methlyated in a 20 ll reaction with 1 ll (4 U/ll) of M.SssI in New England Biolabs buffer 2 with 1X final concentration of freshly prepared S-adenosylmethionine. Reactions were incubated at 378C for 1 h. Nonmethylated controls were also included in all the steps. Treated and nontreated constructs were then used in transient transfection and luciferase assay experiments as described above.
In Vitro Embryo Production
Cumulus oocyte complexes were obtained by aspirating follicles from bovine ovaries collected at a local abbattoir and submitted to in vitro embryo production (IVP) as published previously [62] . Following in vitro maturation and fertilization, at approximately 20 h postinsemination (hpi), presumptive zygotes were denuded by gentle vortexing and transferred to synthetic oviduct fluid medium supplemented with different concentrations (0, 0.1, 1, 10, or 100 ng/ml) of either IL1B, IL3, IL4, IL10, IFNG, LIF, G-CSF (CSF3), or GM-CSF (CSF2); or (3.14 or 314 ng/ml) P4; and cultured in an atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 at maximum humidity. The cleavage rate was recorded at 48 hpi, and the proportion of embryos developing to the blastocyst stage was recorded. Day 7 blastocysts were snap frozen in pools of 10 and stored at À808C for the analysis of transcript abundance of BOLA-NC1 using q-RT-PCR.
q-RT-PCR Embryo NC1 Expression Analysis
Messenger RNA was extracted from five pools of 10 embryos per treatment, using Dynabeads mRNA DIRECT Micro Kit (Dynal AS, Oslo, Norway), and cDNA was synthesized using Superscript III RNase H-Reverse Transcriptase (Invitrogen) supplemented with 200 ng of random primers (Invitrogen) and brought to a final volume of 40 ll with diethylpyrocarbonate. NC1 and PPIA (endogenous control) transcript abundance was assessed using q-RT-PCR by adding a 2 ll aliquot of each cDNA sample to the PCR mix containing gene specific primers (see Table 3 ) and Power Sybr Green PCR Master mix (P/N 4367659; Applied Biosystems) in 96-well plates and amplifying in an automated fluorometer (ABI Prism 7300 Sequence Detection System; Applied Biosystems). All the samples were amplified in duplicate. Amplification conditions were 2 min at 508C, 10 min at 958C, 40 cycles of 15 sec at 958C, and 60 sec at 608C. The data were analyzed using the standard curve method, and means were compared by the Student t-test.
RESULTS
Serial Deletion Analysis Indicates that Positive Regulatory Elements in the Proximal Promoter and Upstream Negative Regulatory Elements Control Basal NC1 Expression
To determine how specific regions along 1.9 kb of the NC1 promoter contribute to constitutive gene expression, a series of nine deletion constructs were designed. Each construct with the corresponding luciferase/renilla ratio is shown in Figure 1 . All nine constructs, when transiently transfected into BEND cells, had significantly higher luciferase activity levels compared to the pGL4.17 basic construct, demonstrating that the NC1 promoter, which could drive luciferase expression, is active in the BEND cell line. Luciferase activity increased sequentially across the first 5 constructs: p-35/þ74 (2.3 6 0.5 RLU, included TATA box), p-84/þ74 (4.0 6 1.2 RLU, included enhancer B and CAAT box), p-128/þ74 (4.9 6 1.5 RLU, included site alpha), p-265/þ74 (11.8 6 2.5 RLU, included GC box, interferon response element (IRE), and enhancer A), and p-577/þ74 (12.5 6 2.3 RLU), which had the highest luciferase activity levels. In summary, elements in the promoter up to À577 bp contributed positively to luciferase activity. Constructs with promoter fragments longer than p-940/þ74 had lower luciferase activity levels relative to the p-577/þ74 construct. In particular, the larger p-1281/þ74 (4.9 6 1.3 RLU) and p-1579/þ74 (4.5 6 1.2 RLU) constructs had significantly lower luciferase activity levels, suggesting the presence of negative regulatory elements or silencer module(s) in the region from À940 to À1579 bp. The MatInspector CHARACTERIZATION OF THE BOLA-NC1 PROMOTER software tool was used to identify transcription factor binding sites within the À940 to À1579 bp with potential repressive effects. Candidates identified in this study include binding sites for the following transcriptional factors: the transcriptional repressor CUT homeodomain protein/CCAAT displacement protein (CDP) [63] , growth factor independence 1 zinc finger protein Gfi-1B (GFI1B) transcriptional repressor [64] , downstream regulatory element-antagonist modulator (DREAM, official symbol: KCNIP3) [65] , octamer-binding factor 1 (OCT1, official symbol: POU2F1) [66] , NK6 homeobox 1 (NKX6-1) [67] , PRDM1 (PRDI binding factor 1) and the murine homolog (transcriptional repressor B lymphocyteinduced maturation protein-1; PRDM1) [68] [69] [70] , and the paired box gene 2 (PAX2) [71] .
IFNG and IFNT Increase Luciferase Activity in NC1
Promoter Constructs and Increase Endogenous NC1 mRNA Expression
To identify regulators of NC1 expression, initially the proximal (p-265/þ74) and extended (p-1829/þ74) NC1 promoter constructs were transiently transfected into BEND cells. Cells were then treated with a panel of cytokines-IL1B, IL3, IL4, IL10, LIF, IFNG, IFNT, GM-CSF (CSF2), and G-CSF (CSF3)-and the steroid hormone P4, known to be important in pregnancy. Three of these cytokines, IFNG, IFNT, and IL4, caused a significant increase in luciferase activity relative to the untreated controls. The results for the IL4 treatment and further elucidation of the mechanism of the IL4 responsiveness are presented below. To more fully investigate which regions of the NC1 promoter were important for the IFNG and IFNT response, the complete series of NC1 promoter deletion constructs generated (p-35/þ74, p-84/þ74, p-128/ þ74, p-265/þ74, p-577/þ74, p-940/þ74, p-1281/þ74, p-1579/þ74, p-1829/þ74) were transiently transfected into BEND cells. Cells were treated with 10 ng/ml of either IFNG or IFNT and luciferase activity was measured 24 h later ( Fig.  2A) . The type II interferon, IFNG, significantly and consistently increased luciferase activity in all the constructs with promoter fragments from À128 to À1579 bp, with a pronounced increased difference between constructs p-128/þ74 and p-265/þ74, indicating the presence of IFNG-responsive elements from À128 to À265 bp that contribute significantly to increased expression. The IRE with adjacent enhancer A is located within this region (À143 to À164 bp). An additional increase in promoter activity was detected between the constructs p-265/ þ74 and p-577/þ74. The NC1 promoter sequence between À265 and À577 bp contains a STAT1 binding site (at position À473 bp), and IFNG is known to exert its effects though homodimerization and translocation of STAT1. No further increase in luciferase activity was detected in constructs greater than À577 bp; however, luciferase levels remained high in promoter fragments from À577 to À1281 bp. The À1281 bp fragment in particular showed the greatest fold increase (5.7-fold) over nontreated controls. Luciferase activity, although significantly elevated, decreased in fragments greater than À1579 bp (the p-1579/þ74 and p-1829/þ74 constructs) compared to maximal levels. Potential repressive transcription factor binding sites within this 250 bp region were also identified using the MatInspector software tool and included YY1 (activator/repressor binding to transcription initiation site, Yin and Yang 1 repressor sites) [72] , GFI1B [64] , and RP58 (zinc-finger repressor protein of 58 kDa, official symbol ZFP238) [73] .
In contrast to IFNG, where sequential significant increases in luciferase expression were detected, the type I interferon, IFNT, significantly increased luciferase activity in two nonsequential promoter regions. The first of these regions was the proximal promoter fragment up to À265 bp, where luciferase activity reached maximal levels and was 1.7-fold greater than nontreated controls. A pronounced increase in luciferase expression was detected between À128 to À265 bp, indicating the presence of elements (detailed above) responsive to IFNT that contribute significantly to increase expression. There was no significant increase in luciferase in fragments from À577 to À940 bp; in fact, luciferase expression was repressed in this 363 bp region. On analysis of the NC1 sequence, two IRF2 binding sites were located within this repressed region. IRF2 is a transcriptional suppressor of type I IFN signaling [74] . The second increase in activity was detected in the three longer promoter fragments (À1281 bp: 2.1-fold; À1579 bp: 3.2-fold; and À1829 bp: 1.6-fold).
The effect of IFNG and IFNT on endogenous NC1 mRNA expression in BEND cells was also investigated to determine if a similar response could be initiated with an in situ promoter. Cells were treated with 10 ng/ml of either IFNG or IFNT, and RNA was harvested 24 h later for qRT-PCR (Fig. 2B) . NC1 mRNA was expressed in BEND cells without additional treatment. However, NC1 mRNA transcript abundance was significantly higher in IFNG-treated cells (12.5-fold, P , 0.001) and IFNT-treated cells (6.2-fold, P , 0.001) relative to nontreated control cells.
Interleukin 4 Regulates the Proximal Promoter of NC1 Through a STAT6 Binding Site
BEND cells transfected with the p-265/þ74 NC1 promoter construct and treated with 10 ng/ml of IL4 for 24 h showed a significant increase in luciferase activity relative to untreated controls indicating that the NC1 proximal promoter was regulated positively by IL4 (Fig. 3A) . Additionally, treatment of BEND cells with 10 ng/ml of IL4 for 24 h also increased NC1 mRNA levels (Fig. 3B) . Further sequence analysis identified a signal transducer and activator of transcription 6 (STAT6) binding site within the p-265/þ74 promoter construct that could confer IL4 responsiveness. Subsequent site-directed mutagenesis of the STAT6 binding site, transfection into BEND cells, and treatment with IL4 demonstrated that within the p-265/þ74 NC1 promoter region, mutating the STAT6 binding site abolished the IL4-induced luciferase expression (Fig. 3A) .
The NC1 Proximal Promoter Harbors a CpG Island that Abrogates Constitutive NC1 Expression when Methylated
An analysis of 652 bp of the proximal promoter region (À577/þ74) for CpG dinucleotides identified the presence of a 309 bp CpG island (Fig. 4A) . The presence of this island prompted an investigation into the possible role methylation plays in regulating the NC1 proximal promoter. The construct (À577/þ74) was in vitro methylated, transfected into BEND cells, and harvested 24 h later for luciferase assay. As shown in Figure 4B , the methylation treatment almost completely abrogated luciferase activity (14 384 6 3266 mean RLUs without treatment and 120 6 12 mean RLUs with methylation treatment, P , 0.001). CHARACTERIZATION OF THE BOLA-NC1 PROMOTER improve in vitro embryo cleavage rate or blastocyst development in our IVP system. However, NC1 mRNA transcript abundance in exposed Day 7 blastocysts was significantly higher in 1 and 100 ng/ml IL3 (1.5-fold, P , 0.01), 1, 10, and 100 ng/ml IL4 (.3-fold, P , 0.001), 10 and 100 ng/ml IFNG (1.7-fold, P , 0.05), and 314 ng/ml P4 (.2-fold, P , 0.001) (Fig. 5, A and B) . Interestingly, NC1 mRNA transcript abundance was significantly lower in Day 7 blastocysts exposed to the lowest dose of IFNG (0.1 ng/ml). There was no significant change (P . 0.05) in blastocyst NC1 expression in the presence of IL1B, LIF, GM-CSF (CSF2), and G-CSF (CSF3).
DISCUSSION
Previous data suggest that NC1 may play a role in early embryo survival and/or maternal-fetal tolerance in cattle. Therefore, the objective of this study was to establish specifically how the NC1 promoter is regulated with a view to gaining some insight into its potential function. Promoter constructs in this study initiated a significant increase in the level of luciferase activity. This is noteworthy because a high level of sequence diversity within the 5 0 upstream regions of BoLA class I genes has been reported, particularly within the TATA box element, and higher levels of sequence diversity could indicate nonfunctionality [75] . NC1, which has a variant TATA box with the sequence TGCAAA, actively drives luciferase expression, providing supporting evidence that the NC1 promoter is functional. A series of conserved DNA sequences in the human MHC-I gene promoter, including enhancer A (containing binding sites for NFKB family members), the ISRE (binding sites for IRF1 and IRF2), site alpha, and enhancer B (part of the SXY module), play important roles in constitutive and cytokine-induced regulation of transcription [31, 76, 77] . Interestingly, these elements, found within 250 bp of the TSS, are found in a similar arrangement on the bovine NC1 promoter, and this study indicates that they also contribute significantly to constitutive NC1 expression with the greatest contribution from the GC box, enhancer A, and IRE elements. The repressive effects on the proximal promoter, originating further upstream, could be due to one or more of the silencer elements identified, which cooperate to tightly regulate endogenous NC1 expression.
IFNG plays a critical role during implantation and maintenance of the placenta in normal pregnancies of mice [78] . Additionally, in the pig, substantial amounts of IFNG are secreted by concepti at Days 15-16 of pregnancy, which act on the endometrium directly [79] [80] [81] . Although the presence of a role for IFNG in bovine early embryo development and maintenance of pregnancy has yet to be determined, recent data from our group have confirmed IFNG mRNA expression in Day 5, 7, 13, and 16 bovine cyclic and pregnant endometrium (Mansouri-Attia et al., unpublished results), and the results of the current study indicate that exposure of embryos in vitro to IFNG generally increased NC1 mRNA expression in Day 7 blastocysts, with an exception observed at the lowest dose (0.1 ng/ml) of IFNG, which elicited a negative effect. Therefore, despite the different types of placentation in cattle and pigs (much less invasive epitheliochorial) compared to mice or humans (hemochorial) [82] , this study suggests a potential role for IFNG in bovine implantation and establishment of pregnancy. The increased endogenous NC1 mRNA expression in Day 7 blastocysts and BEND cells as well as the increased promoter activity in all promoter fragments longer than 128 bp in BEND cells following exposure to IFNG was most likely due to the enhancer A, IRE, and STAT1 binding sites. IFNG signaling, via the Jak-Stat pathway, culminates in the binding of STAT1 homodimers to gamma-activated sequence (TTCN [2] [3] [4] GAA) promoter elements and to a lesser extent ISREs (AGTTTCNNTTTCNC) [83, 84] . STAT1 binding is therefore likely to play a significant role in the IFNG responsiveness of the NC1 promoter. Dampening of the IFNG response was also evident, presumably allowing tighter control of the stimulatory effects of this potent cytokine.
IFNT is critically important as it is responsible for the maternal recognition of pregnancy in ruminants [85, 86] . Production of IFNT by the conceptus, which peaks on Days 14-16, acts on the endometrium to block luteolytic pulses of prostaglandin F2alpha, ensuring functional integrity of the corpus luteum, production of P4, and conceptus survival [47] . Our study also suggests a role for IFNT in the regulation of the bovine NC1 gene. IFNT significantly increased NC1 promoter activity and endogenous NC1 mRNA expression, most likely involving enhancer A and IRE. IFNT signaling results in STAT1 and STAT2 heterodimers associating with IRF9 to form ISGF3, which drives transcription by binding to ISREs in the promoter region of interferon-stimulated genes [87, 88] . Interestingly, the repressed expression also observed could be due to the presence of two IRF2 binding sites as IRF2 is a potent transcriptional repressor of interferon-stimulated gene expression in the ovine uterus [74, 87] . One potential role for IFNT in embryo survival, considering its ability to upregulate NC1 expression, could be to protect the embryo from NK cell lysis. This hypothesis is tentative as it has yet to be experimentally demonstrated that NC1 interacts with inhibitory NK receptors as is the case with HLA-G [8] . Additionally, the presence and location of NK cells within the pregnant bovine uterus would also have to be demonstrated, and to date, very little is known about the role of NK cells during bovine pregnancy [26] .
The pleiotropic cytokine IL4 was also found to significantly upregulate NC1 mRNA expression in both treated BEND cells and IVP blastocysts. The response, which was due to a STAT6 binding site, suggests a potential role for this anti-inflammatory cytokine to increase NC1 expression in trophoblast cells, potentially influencing interactions with the maternal immune system during implantation.
In contrast to our findings for the BEND cells exposed to P4 in culture, NC1 transcription was significantly increased in bovine embryos cultured in the presence of a high (314 ng/ml) concentration of P4. Similarly, increased HLA-G expression has been observed in human cytotrophoblast cells, JEG-3 chorioncarcinoma cells [34] , and mesenchymal stem cells [89] in response to exposure to P4. Subsequently, it was revealed that HLA-G gene expression is upregulated by P4 through the nuclear progesterone receptor (nPRG) complex binding to a unique PRE sequence in the promoter region of the HLA-G gene that showed 60% homology to the wild type mouse mammary tumor virus (MMTV) PRE [90] . Similarly, a potentially unique PRE sequence showing 60% homology to both the HLA-G PRE and the MMTV PRE was also identified in the NC1 promoter region in the current study. Although nPRG expression has been detected in both the bovine cyclic and pregnant endometrium [91] and bovine preimplantation embryos [92] , NC1 expression was only upregulated in the P4-treated blastocysts. These findings suggest a cell-specific P4 modulation of NC1 gene expression.
Methylation of CpG dinucleotides as a mechanism of transcriptional regulation of the NC1 gene was also explored.
This was prompted by the discovery of a 309 bp CpG island in the NC1 proximal promoter region and by reports that aberrant methylation in cloned bovine embryos resulted in abnormalities [93] . DNA methylation in mammalian genomes undergoes two waves of reprogramming during early development; the first wave occurs following fertilization in the preimplantation embryo removing methylation at nonimprinted loci, and the second takes place during male and female germ cell development [94, 95] . This process of demethylation and remethylation of the genome has also been shown to be conserved during bovine preimplantation embryonic development [96] . Our results suggest a potential role for methylation, via a CpG island in the proximal promoter, in the negative regulation of NC1, as luciferase activity from in vitro methylated NC1 constructs was almost completely abrogated. Interestingly, CpG islands have been found in the 5 0 promoter region of the human nonclassical MHC-1 genes HLA-F and HLA-G, but not HLA-E [97] . That study found an inverse relationship between states of methylation and transcriptional activity of the HLA genes in JAR cells (a human choriocarcinoma cell line). Furthermore, it has been suggested that the possible presence of negative regulatory factors and/or methylation could contribute to tissue-specific HLA-G transcription in trophoblast cells [76, 98] . Therefore, the bovine NC1 promoter could be potentially regulated via methylation perhaps during the wave of epigenetic reprogramming that occurs in the preimplantation embryo and/or dynamically in trophoblast cells during the establishment and maintenance of pregnancy.
In summary, our study demonstrates that IFNT, IFNG, and IL4 positively regulate NC1 expression. Of particular importance for bovine reproduction were the novel and significant findings associating IFNT and methylation with NC1 gene expression. IFNT, which is secreted by the conceptus, is a vital determinant of successful reproduction in ruminants, while appropriate epigenetic reprogramming in early embryos is necessary for healthy offspring. The regulation of NC1 by IFNT and epigenetic mechanisms associate this gene with key mediators of embryo development and suggest it has an important functional role in reproduction.
